Non-Small Cell Lung Cancer New Indication: Trastuzumab Deruxtecan for her2 Mutant NSCLC Ulas D. Bayraktar, MD 2023-09-23
GastroEsophageal Cancer New Reference: Trastuzumab Deruxtecan in her2-Positive Advanced Gastroesophageal Cancer Ulas D. Bayraktar, MD 2023-08-20
Breast Cancer New Reference: Trastuzumab Deruxtecan for her2-Positive Breast Cancer Ulas D. Bayraktar, MD 2023-05-20
Uterine Cancer New Indication: Trastuzumab Deruxtecan for her2-Expressing Advanced Uterine Cancer Ulas D. Bayraktar, MD 2023-04-14
Non-Small Cell Lung Cancer New Indication: Trastuzumab Deruxtecan for her2-Mutant NSCLC Ulas D. Bayraktar, MD 2022-03-16
